enow.com Web Search

  1. Ads

    related to: fda approved sleep apnea

Search results

  1. Results from the WOW.Com Content Network
  2. FDA approves Apple Watch sleep apnea detection tool

    www.aol.com/fda-approves-apple-watch-sleep...

    The FDA's green-lighting of the sleep apnea feature comes on the heels of the agency's approval of Apple's AirPods Pro 2 as over-the-counter hearing aids for users with mild to moderate hearing ...

  3. FDA greenlights sleep apnea detection on new Apple Watch - AOL

    www.aol.com/news/fda-greenlights-sleep-apnea...

    The Food and Drug Administration (FDA) has approved Apple’s new sleep apnea detection feature on three of its latest watch models, the company confirmed Monday. The feature — available for the ...

  4. FDA clears Tyler company’s device to treat obstructive sleep ...

    www.aol.com/fda-approves-tyler-company-device...

    The AIO Breathe Device is a “new mandibular repositioning device” that was designed by local sleep physician Dr. Raghavendra V. Ghuge, MD, MBA, DABSM, […] FDA clears Tyler company’s device ...

  5. Hypoglossal nerve stimulator - Wikipedia

    en.wikipedia.org/wiki/Hypoglossal_nerve_stimulator

    Certain patients with obstructive sleep apnea who are deemed eligible candidates may be offered the hypoglossal nerve stimulator as an alternative. FDA-approved hypoglossal nerve neurostimulation is considered medically reasonable and necessary for the treatment of moderate to severe obstructive sleep apnea when all of the following criteria are met: [4]

  6. Solriamfetol - Wikipedia

    en.wikipedia.org/wiki/Solriamfetol

    The U.S. Food and Drug Administration (FDA) approved solriamfetol based primarily on evidence from five clinical trials (Trial 1/NCT02348593, Trial 2/NCT02348606, Trial 3/NCT02348619, Trial 4/NCT02348632, Trial 5 NCT01681121) of 622 patients with narcolepsy or obstructive sleep apnea (OSA). [15]

  7. Vivos Therapeutics Receives Groundbreaking FDA 510(k ...

    lite.aol.com/tech/story/0022/20240918/9232555.htm

    Vivos is poised to disrupt the very significant pediatric obstructive sleep apnea (OSA) market with new FDA clearance and new strategic marketing and distribution model. Vivos’ DNA appliance now approved to reduce snoring and treat moderate to severe OSA in children aged 6 to 17

  1. Ads

    related to: fda approved sleep apnea